Stop the tingle: cold sore care essentials

CPD
By
AP Staff
-

References

  1. Birkmann A, Saunders R. Overview on the management of herpes simplex virus infections: Current therapies and future directions. Antiviral Res 2025;237:106152.
  2. Whitley R, Kimberlin DW, Prober CG. Pathogenesis and disease. In: Arvin A, Campadelli-Fiume G, Mocarski E, et al, eds. Human Herpesviruses: Biology, therapy and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007.
  3. Gopinath D, Koe KH, Maharajan MK, et al. A comprehensive overview of epidemiology, pathogenesis and the management of herpes labialis. Viruses 2023;15(1).
  4. Coppola N, Cantile T, Adamo D, et al. Supportive care and antiviral treatments in primary herpetic gingivostomatitis: a systematic review. Clin Oral Investig 2023;27(11):6333–44.
  5. Shiraki K. Antiviral drugs against alphaherpesvirus. Adv Exp Med Biol 2018;1045:103–122.
  6. Amir J, Harel L, Smetana Z, et al. Treatment of herpes simplex gingivostomatitis with aciclovir in children: a randomised double blind placebo controlled study. BMJ 1997;314(7097):1800–3.
  7. Ducoulombier H, Cousin J, Dewilde A, et al. [Herpetic stomatitis-gingivitis in children: controlled trial of acyclovir versus placebo]. Ann Pediatr (Paris) 1988;35(3):212–16.
  8. Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med 2008;168(11):1137–44.
  9. Adams AJ, Klepser ME. Pharmacy-based assessment and management of herpes labialis (cold sores) with antiviral therapy. Innov Pharm 2020;11(3).
  10. Looker KJ, Magaret AS, May MT, et al. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One 2015;10(10):e0140765.
  11. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006;296(8):964–73.
  12. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002;186 Suppl 1:S3–28.
  13. AlMukdad S, Harfouche M, Farooqui US, et al. Epidemiology of herpes simplex virus type 1 and genital herpes in Australia and New Zealand: systematic review, meta-analyses and meta-regressions. Epidemiol Infect 2023;151:e33.
  14. Zhu S, Viejo-Borbolla A. Pathogenesis and virulence of herpes simplex virus. Virulence 2021;12(1):2670–2702.
  15. Malkin JE. [Natural history of HSV1 and HSV2 transmission modes and epidemiology consequences of HSV infection on HIV infection. Prevention]. Article in French. Ann Dermatol Venereol 2002;129(4 Pt 2):571–6.
  16. Arduino PG, Porter SR. Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features. J Oral Pathol Med 2008;37(2):107–121.
  17. Spruance SL, Overall JC, Jr., Kern ER, et al. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N Engl J Med 1977;297(2):69–75.
  18. Whitley RJ, Kimberlin DW, Roizman B. Herpes simplex viruses. Clin Infect Dis 1998;26(3):541–53;quiz 554–5.
  19. Wollenberg A, Zoch C, Wetzel S, et al. Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases. J Am Acad Dermatol 2003;49(2):198–205.
  20. Kimberlin DW. Herpes simplex virus infections of the newborn. Semin Perinatol 2007;31(1):19–25.
  21. Fatahzadeh M, Schwartz RA. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis and management. J Am Acad Dermatol 2007;57(5):737–63;quiz 764–6.
  22. Raborn GW, McGaw WT, Grace M, et al. Treatment of herpes labialis with acyclovir. Review of three clinical trials. Am J Med 1988;85(2a):39–42.
  23. Shulman JD, Beach MM, Rivera-Hidalgo F. The prevalence of oral mucosal lesions in U.S. adults: data from the Third National Health and Nutrition Examination Survey, 1988–1994. J Am Dent Assoc 2004;135(9):1279–86.
  24. Piperi E, Papadopoulou E, Georgaki M, et al. Management of oral herpes simplex virus infections: the problem of resistance. A narrative review. Oral Dis 2024;30(3):877–94.
  25. UpToDate. Treatment and prevention of herpes simplex virus type 1 in immunocompetent adolescents and adults. 2024. At: www.uptodate.com/contents/treatment-and-prevention-of-herpes-simplex-virus-type-1-in-immunocompetent-adolescents-and-adults
  26. Shulman JD. Prevalence of oral mucosal lesions in children and youths in the USA. Int J Paediatr Dent 2005;15(2):89–97.
  27. van der Wal JE. Herpangina. In: van Krieken JHJM, ed. Encyclopedia of Pathology. Cham: Springer International Publishing; 2017:1–2.
  28. Xing W, Liao Q, Viboud C, et al. Hand, foot and mouth disease in China, 2008–12: an epidemiological study. Lancet Infect Dis 2014;14(4):308–318.
  29. Owotade FJ, Shiboski CH, Poole L, et al. Prevalence of oral disease among adults with primary HIV infection. Oral Dis 2008;14(6):497–9.
  30. Hook EW, 3rd, Marra CM. Acquired syphilis in adults. N Engl J Med 1992;326(16):1060–9.
  31. Sakane T, Takeno M, Suzuki N, et al. Behçet’s disease. N Engl J Med 1999;341(17):1284–91.
  32. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331(19):1272–85.
  33. Dropulic LK, Lederman HM. Overview of infections in the immunocompromised host. Microbiol Spectr 2016;4(4).
  34. Dermatology 5 Expert Group. Herpes simplex virus infections. In: Dermatology 5 Expert Group. Therapeutic guidelines: dermatology. Version 5. Melbourne: Therapeutic Guidelines Limited [amended Mar 2025]. 2022.
  35. Rosa MI, Souza SL, Farias BF, et al. Efficacy of topical 5% acyclovir–1% hydrocortisone cream (ME-609) for treatment of herpes labialis: a systematic review. An Acad Bras Cienc 2015;87(2 Suppl):1415–420.
  36. Castle K. Famciclovir fundamentals. Australian Pharmacist. 2024. At: www.australianpharmacist.com.au/famciclovir-fundamentals/
  37. Chi CC, Wang SH, Delamere FM, et al. Interventions for prevention of herpes simplex labialis (cold sores on the lips). Cochrane Database of Systematic Reviews 2015;2015(8):Cd010095.
  38. Dermatology. Herpes simplex virus infections. Therapeutic guidelines. Melbourne: Therapeutic Guidelines Limited. 2022.
  39. Antibiotics. Antimicrobial dosage modification in kidney impairment. Therapeutic guidelines. Melbourne: Therapeutic Guidelines Limited. 2025.
  40. Pregnancy and Breastfeeding Medicines Guide. Aciclovir. 2025. At: https://thewomenspbmg.org.au/medicines/aciclovir